Elevated B-type natriuretic peptide levels in patients with nonischemic cardiomyopathy predict occurrence of arrhythmic events

被引:25
|
作者
Simon, Tobias [1 ]
Becker, Ruediger [1 ]
Voss, Frederik [1 ]
Bikou, Olympia [1 ]
Hauck, Melanie [1 ]
Licka, Manuela [1 ]
Katus, Hugo A. [1 ]
Bauer, Alexander [1 ]
机构
[1] Univ Heidelberg Hosp, Dept Cardiol, D-69120 Heidelberg, Germany
关键词
nonischemic cardiomyopathy; risk stratification; non sustained ventricular tachycardias; NT-pro BNP; sudden cardiac death;
D O I
10.1007/s00392-007-0629-2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Patients with nonischemic cardiomyopathy (DCM) are at high risk for sudden cardiac death (SCD). However, the predictive value of prophylactic implantation of implantable cardioverter defibrillators (ICD) in this patient cohort is yet unclear. Methods and Results: Whether NT pro BNP levels and/or reproducible non sustained ventricular tachycardias (NSVTs) are predictive for SCD was prospectively tested in 30 patients with DCM and LVEF <= 40%. All patients received Holter-recordings (HR) on three consecutive days and baseline NT-pro BNP levels were determined. Patients were followed for occurrence of ventricular tachyarrhythmias or unexplained syncope. A great degree of variability was found regarding the occurrence of NSVTs (10% had NSVTs in two consecutive HR, 10% in three consecutive HR, 30% in one HR and 50% had no NSVTs). Patients with NSVTs in more than one HR had significantly higher NT-pro BNP levels (first quartile: 715 pg/ml, median 2,176 pg/ml, third quartile 5,755 pg/ml vs. first quartile 273 pg/ml, median 566 pg/ml, third quartile 1,350 pg/ml, P = 0.0388). During a mean follow-up of 21.6 +/- 1.2 months patients with an arrhythmic event had significantly higher NT-pro BNP levels than patients without event (first quartile: 1,002 pg/ml, median 4,075 pg/ml, third quartile 7,777 pg/ml vs. first quartile 173 pg/ml, median 267 pg/ml, third quartile 1,220 pg/ml, P = 0.0135). NT-pro BNP levels of 2,259 pg/ml were identified as optimal cut-off value for the prediction of arrhythmic events (P = 0.0313). In contrast reproducible NSVTs were not predictive for arrhythmic events (P = 0.0960). Conclusion: The present study demonstrates that in patients with DCM the value of reproducible NSVTs in predicting arrhythmic events is low. In contrast raised NT-pro BNP levels significantly correlated with occurrence of symptomatic ventricular arrhythmias. Larger prospective trials are required to confirm these results.
引用
收藏
页码:306 / 309
页数:4
相关论文
共 50 条
  • [41] Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age
    Koch, Andreas M. E.
    Rauh, Manfred
    Zink, Stefan
    Singer, Helmut
    ACTA PAEDIATRICA, 2006, 95 (07) : 805 - 809
  • [42] Renal Clearance of B-Type Natriuretic Peptide and Amino Terminal Pro-B-Type Natriuretic Peptide A Mechanistic Study in Hypertensive Subjects
    van Kimmenade, Roland R. J.
    Januzzi, James L., Jr.
    Bakker, Jaap A.
    Houben, Alphonse J.
    Rennenberg, Roger
    Kroon, Abraham A.
    Crijns, Harry J. G. M.
    van Dieijen-Visser, Marja P.
    de Leeuw, Peter W.
    Pinto, Yigal M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : 884 - 890
  • [43] Prognostic role of B-type natriuretic peptide in patients with diabetes and acute decompensated heart failure
    Aspromonte, N.
    Feola, M.
    Milli, M.
    Scardovi, A. B.
    Coletta, C.
    Carbonieri, E.
    Giovinazzo, P.
    Di Giacomo, T.
    Barro, S.
    Rosso, G. L.
    Ceci, V.
    Milani, L.
    Valle, R.
    DIABETIC MEDICINE, 2007, 24 (02) : 124 - 130
  • [44] B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function
    Jafri, Lena
    Kashif, Waqar
    Tai, Javed
    Siddiqui, Imran
    Azam, Iqbal
    Shahzad, Hira
    Ghani, Farooq
    BMC NEPHROLOGY, 2013, 14
  • [45] Relationship Between Biological Variation in B-Type Natriuretic Peptide and Plasma Renin Concentration in Stable Outpatients With Dilated Cardiomyopathy
    Nishiyama, Keizo
    Tsutamoto, Takayoshi
    Kawahara, Chiho
    Yamaji, Masayuki
    Sakai, Hiroshi
    Yamamoto, Takashi
    Fujii, Masanori
    Horie, Minoru
    CIRCULATION JOURNAL, 2011, 75 (08) : 1897 - 1904
  • [46] B-type natriuretic peptide versus amino terminal pro-B type natriuretic peptide: selecting the optimal heart failure marker in patients with impaired kidney function
    Lena Jafri
    Waqar Kashif
    Javed Tai
    Imran Siddiqui
    Iqbal Azam
    Hira Shahzad
    Farooq Ghani
    BMC Nephrology, 14
  • [47] The Expression of B-Type Natriuretic Peptide After CaCl2-Induced Arrhythmias in Rats
    Cao, Zhi-Peng
    Zhang, Yuan
    Mi, Li
    Luo, Xin-Yi
    Tian, Mei-Hui
    Zhu, Bao-Li
    AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY, 2016, 37 (03): : 133 - 140
  • [48] Can B-Type Natriuretic Peptide (BNP) Levels Serve as an Early Predictor of Clinical Severity in Patients with COVID-19 Pneumonia?
    Cilingir, Buket Mermit
    Askar, Selvi
    Meral, Ayfer
    Askar, Muntecep
    CLINICAL LABORATORY, 2022, 68 (01) : 207 - 213
  • [49] The Change in B-Type Natriuretic Peptide Levels Over Time Predicts Significant Rejection in Cardiac Transplant Recipients
    Kittleson, Michelle M.
    Skojec, Diane V.
    Wittstein, Ilan S.
    Champion, Hunter C.
    Judge, Daniel P.
    Barouch, Lili A.
    Halushka, Marc
    Hare, Joshua M.
    Kasper, Edward K.
    Russell, Stuart D.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2009, 28 (07): : 704 - 709
  • [50] Increased Systemic Levels of Centrally Acting B-Type Natriuretic Peptide Are Associated with Chronic Itch of Different Types
    Nattkemper, Leigh A.
    Kim, Brian S.
    Yap, Qai Ven
    Hoon, Mark A.
    Mishra, Santosh K.
    Yosipovitch, Gil
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2024, 144 (10) : 2267 - 2272